🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to be presenting unpublished work at the Lipids in Brain Diseases Symposium Lipids In Brain Diseases Symposium in September. Hoping to learn a lot and still time to register: ccb.lumc.nl/2nd-symposium-…

We are pleased to announce that the Fourth UCL Queen Square Motor Neuron Disease Centre International Symposium (hybrid event) will take place on Friday 8th September 2023. To register for this exciting meeting - eventbrite.co.uk/e/658581473917

.Adrian Isaacs shares his optimism for new dementia treatments. He & his team of researchers UK Dementia Research Institute are studying the underlying causes of dementia that will one day lead to new treatments for people with diseases like Alzheimer’s. His vital work will help us change the ending.

After failure of ASO trials targeting C9orf72 sense repeats also targeting antisense repeats is now vital. Our new preprint shows a potential approach using CRISPR-CasRx UK Dementia Research Institute UCL Queen Square Institute of Neurology Alex Cammack biorxiv.org/content/10.110…

We have a new LifeArc funded post-doc position to follow up this work, applications close Feb 6th: ucl.ac.uk/work-at-ucl/se…

Brilliant to see former lab member Emma Clayton blazing her own trail!

Delighted to see our study led by Carmelo Milioto revealing a neuroprotective ECM signature in C9FTD/ALS published! Thanks to MND Association UK Dementia Research Institute and many others! nature.com/articles/s4159…

New knock-in #ALS/#FTD mice express less normal C9ORF72 along with repeat dipeptides. They feature a protective collagen response. @UCL ow.ly/U6cW50QOZ8l

A study led by Adrian Isaacs (UK DRI at UCL Queen Square Institute of Neurology) reveals a protective response in cells to early changes in ALS & FTD🧠 The research provides important insight that could lead to new therapeutic avenues to treat FTD & ALS👉buff.ly/3V5EZHc

Our open access opinion in Brain on the disappointing C9 ASO trials and next steps to deliver an effective treatment for C9ALS/FTD co-written with Alex Cammack Rubika Balendra UK Dementia Research Institute UCL Queen Square Institute of Neurology academic.oup.com/brain/article/…

A day in the life of our superstar tech Yash! recorded for Department of Health and Social Care instagram.com/p/C94qZg8oVkT/ UK Dementia Research Institute UCL Brain Sciences In2scienceUK